GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/IBD/Nutrition management puzzle in IBD- Front. Med. 2026
65

Nutrition management puzzle in IBD- Front. Med. 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated February 1, 2026

Nutritional Management in IBD: Current Insights

  1. Importance of Nutrition in IBD:
  • Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is influenced by genetic, immunological, environmental, and gut microbiota factors.
  • Nutrition plays a critical role in managing IBD, not only to support remission and reduce inflammation but also to prevent complications like malnutrition, osteoporosis, and sarcopenia.
  1. Challenges in Nutritional Management:
  • IBD patients often experience malnutrition due to inflammation, dietary restrictions, medication side effects, and rapid weight loss.
  • Vitamin and mineral deficiencies, particularly vitamin D, are common and can lead to complications such as impaired immune function and bone health issues.
  1. Dietary Interventions:
  • Low-FODMAP Diet: Combining a low-FODMAP diet with enteral nutrition has been shown to reduce inflammation (e.g., C-reactive protein levels) and improve nutritional markers like albumin.
  • IgG-Elimination Diet (IgG-ED): This diet has shown promising results in achieving endoscopic remission in IBD patients.
  • Protein Intake: Adequate protein intake is essential to prevent muscle loss and sarcopenia, which can lower the risk of surgical interventions.
  • Vitamin D Supplementation: Maintaining serum levels of 25-hydroxyvitamin D above 75 nmol/L is crucial. Aerosol forms of vitamin D may require lower doses compared to oral supplementation, offering a practical advantage.
  1. Nutritional Risk and Socioeconomic Factors:
  • Malnutrition is prevalent in over one-third of IBD patients, with socioeconomic factors such as lower income contributing to higher disease activity.
  • Nutritional education, socioeconomic support, and regular monitoring of nutritional status are vital components of IBD management.
  1. Preventive and Therapeutic Role of Nutrition:
  • Early implementation of enteral nutrition, anti-inflammatory diets, and personalized nutritional strategies can prevent disease progression and alleviate symptoms.
  • Addressing sarcopenia through dietary and physical interventions can reduce the risk of surgery in IBD patients.
  1. Tailored Nutrition:
  • There is no universal diet for IBD, as different clinical goals (e.g., reducing inflammation, improving nutritional status, achieving remission) require individualised approaches.
  • Comprehensive and personalised nutritional care should be an integral part of IBD therapy.

Related Q&A

66

The PIONIR Trial - Gut Jan. 2026

The PIONIR (Preventing IBD ONset in Individuals at Risk) trial, as described in the study published in Gut, January 2026, focuses on evaluating whether the Tasty&Healthy diet can...

67

Biological and chronic pouchitis (AP&T) - Jan,2026

I am unable to provide information from the future (e.g., January 2026) as my training data only includes content up to October 2023. However, I can provide you...

68

SHINE -1 - Mirikizumab in UC

The SHINE-1 trial was a multicentre, open-label, non-randomised phase 2 study designed to evaluate the efficacy, safety, and pharmacokinetics of mirikizumab in paediatric participants aged 2 to <18...

69

Etrasimod for the symptomatic relief of ulcerative colitis

Etrasimod is a novel oral medication approved for the treatment of moderately to severely active ulcerative colitis (UC). It is a selective sphingosine 1-phosphate (S1P) receptor modulator that...

70

Cardiovascular events observed among patients in the etrasimod clinical programme

The cardiovascular events observed among patients in the etrasimod clinical program were evaluated as part of an integrated safety analysis, focusing on treatment-emergent adverse events (TEAEs) associated with...

71

QUOTIENT Trial: Treat-to-Target Endoscopic Remission in IBD on Advanced Therapies

The QUality Outcomes Treating IBD to Target (QUOTIENT) trial is a significant, pragmatic, open-label, multicentre randomised controlled study that addresses a critical question in the management of inflammatory...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer